JPRN-UMIN000034190已完成2 期
Clinical utility of PET/CT with 18F-FSU-880 for recurrent prostate cancer - PSMA PET for recurrent prostate cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Patients having severe communication problem. 2. Patients with severe general condition. 3. Patients having severe renal dysfunction (eGFR<39mL/min/1.73m3) expected to affect the distribution of [18F]FSU-880.. 4. Patients to whom participating physicians judged to be inappropriate for this study.
研究者
相似试验
已完成
2 期
Clinical utility of PSMA PET/CT for recurrent prostate cancerprostate cancerJPRN-jRCTs051180037akamoto Yuji74
已完成
不适用
Initial clinical evaluation of [18F]FSU-880, a PET probe targeting PSMA; safety, distribution, dosimetry and accumulation in prostate cancer.Prostate cancerJPRN-UMIN000029343Department of Diagnostic Radiology Kyoto University Hospital6
已完成
Unknown
A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer.Advanced or recurrent lung cancerJPRN-UMIN000053550iigata University Medical and Dental Hospital165
招募中
不适用
Evaluation of the use of PET/CT in Adenoid Cystic Carcinoma (ADC)Adenoid Cystic CarcinomaRBR-84nmnm9Eduardo Nóbrega Pereira Lima
已完成
不适用
Evaluation of 18F-FDG-PET/CT in the diagnosis and treatment response of bone metastasis.bone metastasisJPRN-UMIN000005866ational Cancer Center Research Projects Management expenses Grants from the Government to National Cancer Research Center220